Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KIF22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130950 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BCL2L12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESRRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC159 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SALL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on